New York, New York (PRWEB) June 16, 2013
Biomet hip lawsuit claims alleging severe injuries due to the Biomet M2a Magnum Hip Replacement Technique continue to mount in a federal multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an MDL Statistics Report issued on May possibly 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), at least 308 Biomet hip replacement claims have been filed in the federal litigation given that it was established in October 2012. (In re: Biomet M2a Magnum Hip Implant Goods Liability Litigation MDL No. 2391)

We continue to hear from people fitted with metal-on-metal hip implants, including the Biomet M2a Magnum, who allegedly suffered significant complications linked with the failure of their device. It is not surprising that the number of Biomet hip replacement lawsuits filed in this litigation has currently surpassed 300, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is actively filing Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply totally free and confidential case evaluations to men and women who might have been injured by Biomet M2a Magnum implants.

Biomet Hip Replacement Lawsuits
According to court documents, Biomet hip lawsuits allege the metal-on-metal style of the Biomet M2a Magnum implant is prone to put on, and can create higher metal ion levels. This could trigger sufferers to endure metallosis and other adverse tissue reactions, premature device failure and other complications that necessitate revision surgery to get rid of and replace the device. When the multidistrict litigation was established by the JPML in October 2011, 66 Biomet hip replacement claims had been pending in federal courts all through the U.S.

The U.S. Food & Drug Administration (FDA) has been investigating metal-on-metal hip implants because February 2011, amid concerns that metal ions shed from the hips can outcome in metallosis, adverse neighborhood tissue reactions, and early failure. In January, the agency issued new guidance for hip replacement patients fitted with these devices that suggested metal ion testing in those experiencing symptoms of hip implant failure. The FDA also mentioned it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which permitted metal-on-metal hips to come to market without having very first undergoing human clinical trials.*

Biomet M2a Magnum hip recipients who allegedly suffered injuries as a result of the device might be entitled to compensation for their healthcare expenses, lost wages and discomfort and suffering. To understand a lot more about the litigation surrounding this and other metal-on-metal hip implants, please visit Bernstein Liebhard LLPs site, or get in touch with 1 our attorneys today at 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-primarily based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide because 1993, such as those who have been harmed by hazardous drugs, defective healthcare devices and consumer goods. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

Bernstein Liebhard LLP 
10 East 40th Street 
New York, New York 10016 
800-511-5092

Lawyer Marketing.